Prevalence of biofilms in acute infections challenges a longstanding paradigm

Hoiby, 1977, Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey, Acta Pathol Microbiol Scand Suppl, 1 Marrie, 1982, A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead, Circulation, 66, 1339, 10.1161/01.CIR.66.6.1339 Marrie, 1984, Morphology of bacterial attachment to cardiac pacemaker leads and power packs, J Clin Microbiol, 19, 911, 10.1128/jcm.19.6.911-914.1984 Bjarnsholt, 2013, The role of bacterial biofilms in chronic infections, APMIS Suppl, 1, 10.1111/apm.12099 Coenye, 2020, The future of biofilm research - report on the '2019 Biofilm Bash, Biofilms, 2 Burmolle, 2010, Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections, FEMS Immunol Med Microbiol, 59, 324, 10.1111/j.1574-695X.2010.00714.x Hoiby, 2015, ESCMID guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 Kolpen, 2010, Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis, Thorax, 65, 57, 10.1136/thx.2009.114512 Kragh, 2014, Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients, Infect Immun, 82, 4477, 10.1128/IAI.01969-14 Høiby, 2015, ESCMID ∗ guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 Kolpen, 2022, Bacterial biofilms predominate in both acute and chronic human lung infections, Thorax, 10.1136/thoraxjnl-2021-217576 Siemens, 2016, Biofilm in group A streptococcal necrotizing soft tissue infections, JCI Insight, 1, 10.1172/jci.insight.87882 Afzal, 2020, Integrated univariate, multivariate, and correlation-based network analyses reveal metabolite-specific effects on bacterial growth and biofilm formation in necrotizing soft tissue infections, J Proteome Res, 19, 688, 10.1021/acs.jproteome.9b00565 Thornton, 2013, Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media--a potential treatment target, PLoS One, 8, 10.1371/journal.pone.0053837 Bay, 2018, Bacterial aggregates establish at the edges of acute epidermal wounds, Adv Wound Care, 7, 105, 10.1089/wound.2017.0770 Schaber, 2007, Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling, Infect Immun, 75, 3715, 10.1128/IAI.00586-07 Jensen, 2010, The immune system vs. Pseudomonas aeruginosa biofilms, FEMS Immunol Med Microbiol, 59, 292, 10.1111/j.1574-695X.2010.00706.x Bjarnsholt, 2010, Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients, PLoS One, 5, 10.1371/journal.pone.0010115 Marvig, 2015, Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis, Nat Genet, 47, 57, 10.1038/ng.3148 Bjarnsholt, 2013, The in vivo biofilm, Trends Microbiol, 21, 466, 10.1016/j.tim.2013.06.002 Anaya, 2005, Predictors of mortality and limb loss in necrotizing soft tissue infections, Arch Surg, 140, 151, 10.1001/archsurg.140.2.151 Bjarnsholt, 2021, The importance of understanding the infectious microenvironment, Lancet Infect Dis Fleming, 2022, Contribution of Pseudomonas aeruginosa exopolysaccharides Pel and Psl to wound infections, Front Cell Infect Microbiol, 12, 10.3389/fcimb.2022.835754 Kolpen, 2016, Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment, Int J Antimicrob Agents, 47, 163, 10.1016/j.ijantimicag.2015.12.005 Kolpen, 2017, Hyperbaric oxygen sensitizes anoxic Pseudomonas aeruginosa biofilm to ciprofloxacin, Antimicrob. Agents Chemother., 61, 10.1128/AAC.01024-17 Moller, 2019, Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients, J Cyst Fibros: Off J Eur Cystic Fibrosis Soc, 10.1016/j.jcf.2019.01.005 Jensen, 2019, Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: not just hot air, Biofilms, 1 Lerche, 2017, Hyperbaric oxygen therapy augments tobramycin efficacy in experimental Staphylococcus aureus endocarditis, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2017.04.025 Bao, 2022, Organic acids and their salts potentiate the activity of selected antibiotics against Pseudomonas aeruginosa biofilms grown in a synthetic cystic fibrosis sputum medium, Antimicrob. Agents Chemother., 66, 10.1128/AAC.01875-21 Morones-Ramirez, 2013, Silver enhances antibiotic activity against gram-negative bacteria, Sci Transl Med, 5, 10.1126/scitranslmed.3006276 Crabbe, 2019, Antimicrobial tolerance and metabolic adaptations in microbial biofilms, Trends Microbiol, 10.1016/j.tim.2019.05.003 Su, 2015, Fructose restores susceptibility of multidrug-resistant Edwardsiella tarda to kanamycin, J Proteome Res, 14, 1612, 10.1021/pr501285f Singh, 2017, Down-regulation of malate synthase in Mycobacterium tuberculosis H37Ra leads to reduced stress tolerance, persistence and survival in macrophages, Tuberculosis, 106, 73, 10.1016/j.tube.2017.07.006 Slachmuylders, 2018, Elucidation of the mechanism behind the potentiating activity of baicalin against Burkholderia cenocepacia biofilms, PLoS One, 13, 10.1371/journal.pone.0190533 Oosterheert, 2006, Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial, BMJ, 333, 1193, 10.1136/bmj.38993.560984.BE Collaborators, 2022, Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, Lancet Moser, 2019, Antibiotic therapy as personalized medicine - general considerations and complicating factors, APMIS: acta pathologica, microbiologica, et immunologica Scandinavica, 127, 361, 10.1111/apm.12951 Siemens, 2016, Biofilm in group A streptococcal necrotizing soft tissue infections, JCI Insight, 1, e87882, 10.1172/jci.insight.87882